BMC Pregnancy and Childbirth, cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)
Background: Effective disaster preparedness protects pregnant women, a disadvantaged group, and reduces potential harm. Aim: This study was planned to determine the effects of training provided to pregnant women regarding disasters on their knowledge and disaster preparedness levels. Methods: A total of 140 participants (70 in the experimental group and 70 in the control group) who attended the obstetrics and gynecology outpatient clinics of a state hospital in western Turkey between November 2023 and December 2024 and met the inclusion criteria were included in the study. Data were collected through face-to-face interviews using pre-test and post-test forms and standardized questionnaires. Results: It was determined that 34.3% of the pregnant women in both the experimental and control groups were aged between 26 and 30 years. In the experimental group, 34.3% of the participants were high school graduates, whereas 34.3% of those in the control group were undergraduate graduates. The mean gestational week was 33.41 ± 7.25 in the experimental group and 20.79 ± 11.68 in the control group. Following the training intervention, disaster knowledge levels of pregnant women in the experimental group increased markedly, with no incorrect responses observed in the post-test assessment. A statistically significant difference was found between the post-test total scores of the Disaster Preparedness Scale in the experimental and control groups (t = 23.23, p < 0.001, Cohen’s d = 3.93), indicating a very large effect size of the training intervention. In contrast, no statistically significant difference was found between the pre-test scores of the two groups (t = − 1.04, p = 0.30). Conclusions: The training provided to pregnant women, a vulnerable group, emphasized the importance of pre-disaster preparedness and increased their knowledge and awareness. These findings highlight the need to integrate disaster preparedness education into routine prenatal care programs and broader clinical practice. Trial registration: Registration was made to the Iran Randomized Clinical Research Center on June 29, 2024, with the ID IRCT20240531061964N1.